Next Article in Journal
Advanced Pharmaceutical Science and Technology in Israel
Previous Article in Journal
Synthesis and Characterization of Transferrin Receptor-Targeted Peptide Combination SN-38 and Rucaparib Conjugate for the Treatment of Glioblastoma
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Qi et al. Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π–π Stacking and Its Therapeutic Application in Bladder Cancer. Pharmaceutics 2021, 13, 1776

1
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Pharmaceutics, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
2
Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Pharmaceutics 2025, 17(6), 733; https://doi.org/10.3390/pharmaceutics17060733
Submission received: 27 May 2025 / Accepted: 28 May 2025 / Published: 3 June 2025

Error in Figure

In the original publication [1], there was a mistake in Figure 10 as published. Figure 10A,B were unintentionally duplicated. The corrected Figure 10 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Qi, L.; Liu, C.; Zhang, Y.; Zhang, Z.; Duan, H.; Zhao, H.; Xin, X.; Chen, L.; Jin, M.; Guan, Y.; et al. Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π–π Stacking and Its Therapeutic Application in Bladder Cancer. Pharmaceutics 2021, 13, 1776. [Google Scholar] [CrossRef] [PubMed]
Figure 10. Cell uptake efficiency in vitro. (A) Observation of MB49 cells by confocal microscopy after treatment with C6 solution, C6 NPs, and C6 RGD-NPs. Scale bar = 100 µm. (B) Observation of MB49 cells by confocal microscopy after treatment with C6 RGD-NPs for 15, 60, and 120 min., respectively. Scale bar = 100 µm. (C,D) Analysis of the cellular uptake of the control, C6 solution, C6 NPs, and C6 RGD-NPs in MB49 cells by flow cytometry and mean fluorescence intensity. (E,F) Analysis of the C6 RGD-NP uptake on MB49 cells for 15, 60, and 120 min by flow cytometry and the mean fluorescence intensity, *** p < 0.001 to control.
Figure 10. Cell uptake efficiency in vitro. (A) Observation of MB49 cells by confocal microscopy after treatment with C6 solution, C6 NPs, and C6 RGD-NPs. Scale bar = 100 µm. (B) Observation of MB49 cells by confocal microscopy after treatment with C6 RGD-NPs for 15, 60, and 120 min., respectively. Scale bar = 100 µm. (C,D) Analysis of the cellular uptake of the control, C6 solution, C6 NPs, and C6 RGD-NPs in MB49 cells by flow cytometry and mean fluorescence intensity. (E,F) Analysis of the C6 RGD-NP uptake on MB49 cells for 15, 60, and 120 min by flow cytometry and the mean fluorescence intensity, *** p < 0.001 to control.
Pharmaceutics 17 00733 g010
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Qi, L.; Liu, C.; Zhang, Y.; Zhang, Z.; Duan, H.; Zhao, H.; Xin, X.; Chen, L.; Jin, M.; Guan, Y.; et al. Correction: Qi et al. Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π–π Stacking and Its Therapeutic Application in Bladder Cancer. Pharmaceutics 2021, 13, 1776. Pharmaceutics 2025, 17, 733. https://doi.org/10.3390/pharmaceutics17060733

AMA Style

Qi L, Liu C, Zhang Y, Zhang Z, Duan H, Zhao H, Xin X, Chen L, Jin M, Guan Y, et al. Correction: Qi et al. Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π–π Stacking and Its Therapeutic Application in Bladder Cancer. Pharmaceutics 2021, 13, 1776. Pharmaceutics. 2025; 17(6):733. https://doi.org/10.3390/pharmaceutics17060733

Chicago/Turabian Style

Qi, Lingling, Chao Liu, Yingying Zhang, Zheao Zhang, Hongxia Duan, Heming Zhao, Xin Xin, Liqing Chen, Mingji Jin, Youyan Guan, and et al. 2025. "Correction: Qi et al. Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π–π Stacking and Its Therapeutic Application in Bladder Cancer. Pharmaceutics 2021, 13, 1776" Pharmaceutics 17, no. 6: 733. https://doi.org/10.3390/pharmaceutics17060733

APA Style

Qi, L., Liu, C., Zhang, Y., Zhang, Z., Duan, H., Zhao, H., Xin, X., Chen, L., Jin, M., Guan, Y., Gao, Z., & Huang, W. (2025). Correction: Qi et al. Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π–π Stacking and Its Therapeutic Application in Bladder Cancer. Pharmaceutics 2021, 13, 1776. Pharmaceutics, 17(6), 733. https://doi.org/10.3390/pharmaceutics17060733

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop